On Monday, Artiva Biotherapeutics Inc (NASDAQ: ARTV) was 35.66% up from the session before settling in for the closing price of $2.44. A 52-week range for ARTV has been $2.29 – $17.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 125.25% over the last five years. When this article was written, the company’s average yearly earnings per share was at 49.54%. With a float of $11.99 million, this company’s outstanding shares have now reached $24.29 million.
The firm has a total of 89 workers. Let’s measure their productivity. In terms of profitability, gross margin is 100.0%, operating margin of -26806.37%, and the pretax margin is -21986.85%.
Artiva Biotherapeutics Inc (ARTV) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Artiva Biotherapeutics Inc stocks. The insider ownership of Artiva Biotherapeutics Inc is 50.78%, while institutional ownership is 63.16%. The most recent insider transaction that took place on Jul 22 ’24, was worth 99,999,996. In this transaction Director of this company bought 8,333,333 shares at a rate of $12.00, taking the stock ownership to the 8,693,579 shares. Before that another transaction happened on Jul 22 ’24, when Company’s 10% Owner bought 833,333 for $12.00, making the entire transaction worth $9,999,996. This insider now owns 1,182,054 shares in total.
Artiva Biotherapeutics Inc (ARTV) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 49.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.09% during the next five years compared to -64.01% drop over the previous five years of trading.
Artiva Biotherapeutics Inc (NASDAQ: ARTV) Trading Performance Indicators
You can see what Artiva Biotherapeutics Inc (ARTV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 15.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 322.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.94, a number that is poised to hit -0.71 in the next quarter and is forecasted to reach -2.84 in one year’s time.
Technical Analysis of Artiva Biotherapeutics Inc (ARTV)
Analysing the last 5-days average volume posted by the [Artiva Biotherapeutics Inc, ARTV], we can find that recorded value of 1.85 million was better than the volume posted last year of 0.23 million. As of the previous 9 days, the stock’s Stochastic %D was 16.87%. Additionally, its Average True Range was 0.71.
During the past 100 days, Artiva Biotherapeutics Inc’s (ARTV) raw stochastic average was set at 9.61%, which indicates a significant decrease from 36.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 168.68% in the past 14 days, which was higher than the 116.64% volatility it showed in the past 100 days.
Now, the first resistance to watch is $4.78. This is followed by the second major resistance level at $6.24. The third major resistance level sits at $7.54. If the price goes on to break the first support level at $2.02, it is likely to go to the next support level at $0.72.
Artiva Biotherapeutics Inc (NASDAQ: ARTV) Key Stats
There are 24,363K outstanding shares of the company, which has a market capitalization of 80.65 million. As of now, sales total 250 K while income totals -65,370 K. Its latest quarter income was 0 K while its last quarter net income were -17,840 K.
